Response to rituximab in 3 children with opsoclonus-myoclonus syndrome resistant to conventional treatments. [electronic resource]
- European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society Mar 2012
- 192-5 p. digital
Publication Type: Case Reports; Journal Article
1532-2130
10.1016/j.ejpn.2011.05.013 doi
Adrenocorticotropic Hormone--therapeutic use Anti-Inflammatory Agents--therapeutic use Antibodies, Monoclonal, Murine-Derived--therapeutic use Ataxia--drug therapy Child Behavior Disorders--etiology Dexamethasone--therapeutic use Drug Resistance Electroencephalography Gait Disorders, Neurologic--drug therapy Humans Immunoglobulins, Intravenous--therapeutic use Infant Magnetic Resonance Imaging Male Opsoclonus-Myoclonus Syndrome--drug therapy Prednisone--therapeutic use Rituximab Speech Disorders--drug therapy Treatment Outcome Tremor--drug therapy Virus Diseases--complications